Latest stock market news and AI sentiment analysis for the HEALTHCARE sector — NSE & BSE coverage
Get the latest HEALTHCARE sector news for Indian stock markets. AnalystBuddy covers NSE and BSE stocks in the HEALTHCARE sector with AI-powered sentiment analysis, breaking news, and market impact ratings — updated daily.
STAR: FY26 profit surged on demerger gain, with strong pharma focus and Rs. 5/share dividend proposed
Strides Pharma Q4 Results: Operational strength lifts profit despite softer margins
Strides Pharma Science March-Quarter Consol Net Profit 1.27 Billion Rupees
Glenmark Pharma Launches Vancomycin Hydrochloride For Injection USP, 500 Mg/Vial And 1 G/Vial
India's top IT firms pay record Rs 1 lakh crore dividend even as stocks take a beating
Dr Reddy's Laboratories launches generic semaglutide injection in Canada
BALRAMCHIN: FY 2025-26 saw revenue growth, stable margins, and a confirmed ₹3.50/share dividend
SAIL Q4 profit jumps 47% amid record production & sales, beats estimates; declares dividend
Deepak Nitrite Q4 net profit, margins rise despite revenue dip; declares ₹7.50 dividend
DEEPAKNTR: FY26 consolidated net profit fell to ₹550.66 crore on lower revenue; ₹7.5 dividend proposed
Key facts: Cipla Q4 EBITDA INR9.5bn; JPMorgan upgrade; US run‑rate $800-950m; shares up 8%
Key facts: Airtel: record FY26; 50% dividend; 146.8M for 16.31% Africa; analysts raise targets
Trade Spotlight: How should you trade Indus Towers, NMDC, Max Healthcare, BSE, KEI Industries, and others on May 15?
ROUTE: Profitability improved despite revenue decline, with margins up and dividend raised by 50%
Apollo Tyres Q4 profit jumps 3x, aided by deferred tax revision; declares ₹2.50 final dividend
MEDANTA: Strong revenue and profit growth, regulatory impacts, and dividend proposed for FY26
APOLLOTYRE: Strong revenue and profit growth, higher dividend, and major restructuring costs recognized
Market at Close | Bharti Airtel, Cipla lead rally as Sensex jumps 790 points, Nifty tops 23,650
JSW Steel Q4 results: Net profit surges to Rs 19,243 cr due to one-time gain, declares dividend of Rs 7.1
JSW Steel Q4 revenue tops estimates, margin expands; dividend declared
BHARTIARTL: Record FY 2026 revenue, robust margins, and digital growth drive strong outlook and higher dividends
Cipla shares rise 8% to become top Nifty gainer as brokerages largely positive post-Q4 results
Cipla shares jump 7% after at least six analyst upgrades on Q4 results, outlook
Accumulate Cipla; target of Rs 1400: Prabhudas Lilladher
Lupin Receives U.S. FDA Approval for Famotidine Injection, USP
LICHSGFIN: Net profit and revenue rose year-over-year, with improved asset quality and a ₹10 dividend recommended
Metropolis Healthcare Q4 profit zooms 2x on higher revenue, margins; declares dividend
DLF Q4 net flat, revenue slips 42%; new bookings at ₹20,143 cr, declares dividend
Metropolis Health Declares 2Nd Interim Dividend Of 1 Rupee Per Share
Lupin gets FDA nod for famotidine injection to treat ulcers, GERD
Lupin Receives U.S. FDA Approval For Famotidine Injection, USP
DLF: Revenue and profit rose, dividend proposed, and major legal matters remain unresolved
DLF Recommends Dividend Of 8 Rupees Per Share For FY 2025-26
SHREECEM: Strong Q4 growth, higher capacity, and robust dividend amid cost and geopolitical headwinds
Cipla targets $1 billion US run-rate, guides 18.5-20% Ebitda margin for FY27
CIPLA: Strong Q4/FY26 growth, ambitious FY27 guidance, and focus on innovation and complex generics
Dr Reddy's revives India business in FY26 with portfolio, productivity reset
Bharti Airtel Q4 results: Net profit falls 34% to Rs 7,325 cr, misses estimates; telco declares Rs 24 dividend
Cipla Q4 Results: Net profit plunges 55% to Rs 555 crore as revenue declines, expenses rise; dividend announced
CIPLA: Record FY26 revenue and robust growth in India, North America, and Africa, with strong cash reserves
Cipla Recommends Final Dividend of INR13.00/Shr >500087.BY
Cipla Q4 Results: Stock gains after US sales, ex-impairment margins meet expectations
Cipla 4Q Rev INR65.41B Vs. INR67.30B >500087.BY
Cipla Q4 profit misses estimates as US market competition weighs
Indian drugmaker Cipla's fourth-quarter profit misses view on weak US sales
Cipla 4Q Net INR5.55B Vs. Net INR12.22B >500087.BY
HINDPETRO: Net profit more than doubled year-over-year, with robust margins and a final dividend proposed
HPCL Q4 Results: Operating performance strong; Board approves highest dividend in five years
CIPLA: FY26 revenue rose to ₹28,162.59 crore; net profit was ₹3,861.74 crore; ₹13 dividend proposed
Indian drugmaker Cipla misses Q4 profit view on weak US sales
Cipla Q4 Consol Net Profit 5.55 Billion Rupees
Accumulate Dr Reddys Laboratories; target of Rs 1400: Prabhudas Lilladher
Dr Reddy's Laboratories Ltd reports results for the quarter ended March 31 - Earnings Summary
PFIZER: FY26 revenue rose, net profit reached ₹722.43 crore, and a ₹75/share dividend is proposed
Pfizer Q4 profit falls despite revenue, EBITDA growth; ₹75 dividend declared
India's Dr Reddy's plans generic Ozempic launch in Canada this month, eyes India semaglutide tablet roll-out
DIXON: Strong revenue and profit growth, dividend proposed, and major business expansions completed
BERGEPAINT: Q4 FY26 delivered robust profit growth and margin expansion, with a Rs 4.00 dividend recommended
Dr. Reddy's Laboratories Board Recommends Final Dividend of INR8/Shr >500124.BY
DRREDDY: FY26 profit dropped 24% YoY on one-offs; revenue up 3.2% YoY, dividend of ₹8/share proposed
Indian drugmaker Dr Reddy's quarterly profit slumps on cancer therapy impairments
India's Dr Reddy's Looking To Launch Semaglutide In Canada In Next Few Days In This Month
Dixon Tech Q4 Results: Revenue up 2%, margin narrows but better than feared; Dividend declared
Berger Paints Q4 profit jumps 28% as margins improve; declares final dividend
Dr Reddy's Got Marketing Authorization For Generic Semaglutide Tablets In India From Dcgi
Indian drugmaker Dr Reddy's posts quarterly profit slump
MCX: Consolidated net profit after tax surged to ₹1,331.55 crore, with a ₹8/share dividend proposed
UPL: FY26 revenue and net profit surged, with strong segment results and a 300% dividend proposed
CANBK: Net profit and asset quality improved, dividend recommended, and no outstanding defaults reported
SHYAMMETL: FY 2026 saw robust growth, a ₹2.70/share dividend, and major expansion plans approved
Accumulate Lupin; target of Rs 2500: Prabhudas Lilladher
DIVISLAB: Strong Q3 growth, robust exports, and custom synthesis projects on track for 2027 commercialization
Cipla, Pfizer India partner for exclusive marketing of four brands
NOCIL Announces Final Dividend of ₹2.00, Ex-Date Due Tomorrow
Medanta operator Global Health plans ₹550 crore hospital in Varanasi
Global Health To Develop And Lease Hospital Building Suitable For 400 Beds
Dr Lal PathLabs Q4 Results: Profit slips 15% despite strong revenue growth; ₹4 dividend announced
KFINTECH: FY26 revenue up 19.3% YoY, EBITDA margin at 40.7%, and dividend of ₹12.0 per share proposed
KFin Tech Q4 revenue rises 23%, but profit dips and margins shrink; ₹12 dividend announced
Birlasoft Recommends Final Dividend Of 4 Rupees Per Share
AstraZeneca Pharma India gets CDSCO nod to import and market datverzo breast cancer drug
Astrazeneca Pharma India Dec-Quarter PAT 325.9 Million Rupees
AstraZeneca Pharma receives CDSCO nod for cancer treatment drug
Astrazeneca Pharma India Ltd Receives Permission To Import Durvalumab
AstraZeneca Pharma shares gain as it receives CDSCO nod for import of endometrial cancer treatment drug
Algorae Pharmaceuticals And Zydus Enter Exclusive Commercial Agreement
VBL: Strong Q1 CY2026 growth with robust sales, African expansion, and higher interim dividend
VBL: Q1 2026 saw robust revenue and profit growth, interim dividend, and key acquisitions in South Africa
TIINDIA: Q3 revenue up 20% YoY to Rs.5,801 Cr; PAT at Rs.279 Cr; Rs.2/share interim dividend declared
Tube Investments Of India Declares Interim Dividend Of 2 Rupees Per Share
Tube Investments Q3 Results: Profit jumps 18%, margin expands; dividend declared
TATAELXSI: FY 2025-26 profit declined on a one-time labor provision, with a ₹75 dividend recommended
Tata Elxsi Q4 profit doubles, margin expands; ₹75 dividend declared
Tata Communications Q4 profit slides, margin improves; ₹17.5 dividend declared
SYNGENE: Revenue rose but net profit fell on higher exceptional costs; dividend of ₹1.25 per share proposed
SUPREMEIND: FY26 revenue rose to Rs. 11,217.68 crores, with a Rs. 36/share dividend and no outstanding debt
Strides Pharma Science Ltd Dec-Quarter Consol Net Profit 2.02 Billion Rupees
Strides Pharma Q3 Results: Stock surges 10% after Co maintains US biz outlook, margins expand
ROUTE: Q2 FY26 saw higher revenue but a net loss from major vendor write-offs; interim dividend declared
Poonawalla Fincorp Q4 profit jumps over 3x, no dividend announced
POLYCAB: Strong revenue and profit growth, dividend proposed, and key management changes announced
PI Industries beats the Street, net profit dips 17% in Q3; declares ₹5 dividend
PIIND: Quarterly profit boosted by one-time gain; interim dividend declared amid lower revenue
Page Industries Q3 Results: Stock jumps after steady operating performance; Dividend announced
PAGEIND: Quarterly profit impacted by new labour code costs; interim dividend of Rs. 125 declared
NAVINFLUOR: FY26 revenue and profit surged, with a final dividend of ₹8.60/share and QIP funds fully deployed
Dividend Alert: Navin Fluorine declares 430% final payout after Q4 net profit doubles
Metropolis Healthcare launches Centre of Genomics to scale precision diagnostics in India
Buy Max Healthcare Institute; target of Rs 1300: Anand Rathi
Max Healthcare Institute shares rise 2% in Monday's trading
Hospital stocks are pricing in the risks of US-Iran war, analysts say; Here are their top picks
Max Healthcare Institute shares rise nearly 1% amid volume surge
LTTS: Revenue up 14% YoY, PAT ₹12,792M, record dividend, strong growth in Sustainability and Tech
IRFC Declares Dividend Of 1.05 Rupees Per Share
Indian Railway Finance Corporation to consider second interim dividend on March 9
IEX: FY26 net profit and EPS rose significantly; ₹2/share final dividend recommended
Glenmark Specialty SA Receives U.S. FDA Approval For Fluticasone Propionate Inhalation Aerosol Usp, 44 Mcg Per Actuation, With 180-Day Competitive Generic Therapy Exclusivity
Trade Spotlight: How should you trade Avenue Supermarts, Glenmark, Bharat Dynamics, Torrent Pharma, Cummins India, and others on March 10?
Glenmark Pharma launches Potassium Phosphates Injection in US market
Glenmark gets USFDA nod for generic Flovent with 180‑day CGT exclusivity
Buy Fortis Healthcare; target of Rs 1050: Prabhudas Lilladher
Fortis Healthcare shares gain as analysts see up to 25% upside post solid Q3
DALBHARAT: Revenue and net profit increased, with a Rs. 5/share dividend and unmodified audit opinions
ATGL: FY 2025-26 saw revenue growth and stable profit, with a ₹0.25/share dividend proposed
Apollo Tyres Q3 net profit jumps 40%; revenue, margins grow; dividend of ₹3.50 declared
Alkem Laboratories gets DCGI nod for Semaglutide Injection; share price fall marginally
Alkem Labs Launches Semaglutide Injection In India With Weekly Therapy Starting At 450 Rupees
Ajanta Pharma March-Quarter Consol Profit 2.67 Billion Rupees
Mankind Pharma Says Search And Seizure/Inspection Operation Conducted By GST Department At Bharat Serums And Vaccines
Mankind Pharma shares gain 3% on acquiring Rivotril brand from Roche for Indian market
Mankind Pharma Q3 net profit rises 9.5% as BSV boost offsets acute weakness
Mankind Pharma Says Tax Penalty Of 10.2 Million Rupees Dropped
Mankind Pharma Says Tax Penalty Of 4.6 Million Rupees Dropped
Lodha Developers Q4 Results | Net profit up 9% on higher revenue; declares dividend
LODHA: Strong revenue and profit growth, higher dividend, and solid financial ratios for FY26
United Breweries Q4 falls short of estimates; net profit up 4%, declares ₹10 dividend
Trent Q4 PAT rises 30% to Rs 455 crore; firm announces 1:2 bonus share issue, Rs 6 dividend
TATACONSUM: Strong revenue and profit growth, with a Rs 10 per share dividend recommended for FY26
Neutral Torrent Pharma; target of Rs 4300: Motilal Oswal
SRF: Strong revenue and profit growth driven by Chemicals and Films, with no final dividend declared
Heron Neutron To Team Up Siemens Healthcare on Developing Theranostics Platform
BRITANNIA: Revenue and profit rose in FY26, with a ₹90.50 dividend and notable one-time items
Britannia Q4 profit jumps 22%, announces ₹90.5 dividend as sales stay strong
OFSS: Consolidated revenue and net profit grew year-over-year, with a ₹270/share interim dividend declared
Apollo Hospitals Says Shareholding In AHLL Increases To 99.42%
Apollo Hospitals shares now part of Citi's 'Pan-Asia Focus List'; Stock surges
NMDC: Strong revenue growth, interim dividend declared, but significant contingent liabilities persist
Muthoot Finance declares ₹30 interim dividend for FY26; April 17 set as record date
Muthoot Finance sets April 13 record date for interim dividend
MARICO: Revenue and profit rose on strong segment results and acquisitions, with a Rs. 4 dividend proposed
LUPIN: Robust revenue and profit growth, major legal settlements, and a ₹18/share dividend recommended
Lupin Receives U.S. FDA Approval For Glycerol Phenylbutyrate Oral Liquid
Lupin March-Quarter Consol Net Profit 14.6 Billion Rupees
DIVISLAB: Strong Q3 growth, robust exports, and custom synthesis projects on track for 2027 commercialization
Divi's Laboratories Q3 Consol Net Profit 5.83 Billion Rupees
Indian contract drug maker Divi's misses profit view on high material costs, one-off labour charge
Divi's Labs Q3 misses street estimates on profit; posts strong operating performance
DIVISLAB: Q3 FY26 consolidated income grew 12% YoY to ₹2,692 crores, with PAT at ₹583 crores
HAVELLS: FY26 revenue and profit rose, with strong segment growth, dividend hike, and Board changes
Pharma Q4 preview: Domestic business offset US pain, higher freight costs may hit margins
Cipla gets 2 observations after USFDA Goa plant inspection, says will address concerns
Cipla Receives U.S. FDA Approval For First AB-Rated Generic Of Ventolin® Hfa
Godrej Consumer Q4 net profit rises 10%; declares ₹5 interim dividend
Dabur Q4 Results: FMCG major beats estimates on strong rural demand; dividend declared
DABUR: Revenue and profit rose, dividend proposed, and financial ratios improved year-over-year
Cipla jumps nearly 5% after USFDA nod for generic Ventolin inhaler
Cipla Receives USFDA Approval For First AB-Rated Generic Of Ventolin HFA
Dr Reddy's Clarifies News Report Dr. Reddy's Laboratories Still Awaiting Approval For A Major Near-Term Trigger
Organon Rides the Pharma M&A Wave With Sun Takeover. The Stock Sizzles. - Barrons.com
Organon Shares Rally 16% in Premarket as Sun Pharma Announces Buyout
Sun Pharma to Buy U.S. Healthcare Firm Organon in $11.75 Billion Deal - WSJ
SHREECEM: Revenue and profit rose sharply, dividend declared, and new plant commissioned; no new debt issued
Shree Cement Q4 operating profit slips 9% despite 11% volume growth; dividend declared
Shree Cement Final Dividend Of 70 Rupees Per Equity Share
Adani Enterprises slips into ₹221 crore Q4 loss, approves ₹15,000 crore fundraise; declares dividend
BRITANNIA: Revenue and profit rose in FY26, with a ₹90.50 dividend and notable one-time items
Britannia Q4 profit jumps 22%, announces ₹90.5 dividend as sales stay strong
Apollo Hospitals Says Shareholding In AHLL Increases To 99.42%
Apollo Hospitals shares now part of Citi's 'Pan-Asia Focus List'; Stock surges
Nestle India stock jumps 3%, extends gain after strong Q4 results beat Street; brokerages divided on valuation comfort
UltraTech Cement stock steady today after Q4 beat, brokerages retain bullish ratings; special dividend in focus
Divi's Laboratories Q3 Consol Net Profit 5.83 Billion Rupees
Divi's Labs Q3 misses street estimates on profit; posts strong operating performance
DIVISLAB: Q3 FY26 consolidated income grew 12% YoY to ₹2,692 crores, with PAT at ₹583 crores
Indian contract drug maker Divi's misses profit view on high material costs, one-off labour charge
Cipla jumps nearly 5% after USFDA nod for generic Ventolin inhaler
Cipla Receives USFDA Approval For First AB-Rated Generic Of Ventolin HFA
Pharma Q4 preview: Domestic business offset US pain, higher freight costs may hit margins
Cipla gets 2 observations after USFDA Goa plant inspection, says will address concerns
Cipla Receives U.S. FDA Approval For First AB-Rated Generic Of Ventolin® Hfa
Dr Reddy's Clarifies News Report Dr. Reddy's Laboratories Still Awaiting Approval For A Major Near-Term Trigger
Organon Shares Rally 16% in Premarket as Sun Pharma Announces Buyout
Sun Pharma to Buy U.S. Healthcare Firm Organon in $11.75 Billion Deal - WSJ
Organon Rides the Pharma M&A Wave With Sun Takeover. The Stock Sizzles. - Barrons.com
Adani Enterprises slips into ₹221 crore Q4 loss, approves ₹15,000 crore fundraise; declares dividend
Nestle India stock jumps 3%, extends gain after strong Q4 results beat Street; brokerages divided on valuation comfort
UltraTech Cement stock steady today after Q4 beat, brokerages retain bullish ratings; special dividend in focus
These major companies are rewarding shareholders with hefty dividends this year
MCX Q4 net profit zooms nearly 4x, revenue more than triples; declares dividend
LUPIN: Record sales and profitability in FY 2026, with robust growth across all major geographies
These major companies are rewarding shareholders with hefty dividends this year
India's Global Health gains; Jefferies sees losses easing at Noida hospital
Global Health Approved Execution Of Agreement For 79 Bedded Cancer Care Hospital In Indore
Here's why these two healthcare stocks are surging up to 18% on Monday
Jyothy Labs Says Dividend 3.5 Rupees Per Share
Mankind Pharma Buys Rivotril Brand From Roche For India
Mankind Pharma buys rights to Rivotril, deepening central nervous system therapy push
Buy Mankind Pharma; target of Rs 2640: Motilal Oswal
LUPIN: Record sales and profitability in FY 2026, with robust outlook despite rising competition
LUPIN: Q4 FY26 delivered double-digit sales and profit growth, led by US and India, with strong margins
Lupin shares may react to record US sales in Q4, strong operating performance
Tata Consumer Products Q4 net profit surges 21%, beats estimates; declares dividend
ROUTE: FY26 net profit was ₹256.94 crore on revenue of ₹4,408.21 crore, with ₹11 per share dividend proposed
ROUTE: Gross profit margin rose to 22.9% as revenue mix shifted, with stable margins and higher dividends guided
Polycab India Recommends Dividend Of 47 Rupees Per Equity Share
MRF: FY26 saw robust revenue and profit growth, a Rs 235/share dividend, and key management changes
MRF Dividend: Board approves joint-highest payout ever for shareholders; Details here
KPIT Technologies Ltd Recommends Final Dividend Of 5.25 Rupees Per Share
ESCORTS: Strong profit growth and record dividend, boosted by the RED Business sale
Airtel Africa delays mobile money division's IPO as Iran war-driven costs loom
CAMS Q4 Results | Net profit rises 11%; recommends ₹4 dividend
BSOFT: FY26 profit and revenue stable; final dividend of ₹4/share recommended; one-time labour cost hit
ALKYLAMINE: FY 2025-26 saw steady revenue, strong cash growth, and a Rs. 10/share dividend proposal
Alkyl Amines Q4 Results: Profit, revenue largely flat; dividend declared
Alkem Labs Says Order-In-Appeal Drops Tax Demand Of 696.6 Million Rupees
Alkem Labs Says US FDA Conducts Unannounced Inspection At Alkem CRO Facility
Ajanta Pharma Q4 net profit rises 18% despite ₹42 crore forex loss; revenue grows 21%
Buy Ajanta Pharma; target of Rs 3400: Prabhudas Lilladher
Buy Ajanta Pharma; target of Rs 3400: Motilal Oswal
Algorae Pharmaceuticals Executes License & Supply Agreement With Torrent Pharma
PIDILITIND: Double-digit revenue and profit growth with margin expansion and high dividend payout
Dr Reddy's Laboratories Ltd expected to post earnings of ₹13.28 a share - Earnings Preview
TATACONSUM: Strong revenue and profit growth, with a Rs 10 per share dividend recommended for FY26
Tata Consumer Products Q4 net profit surges 21%, beats estimates; declares dividend
Dr Reddy's Laboratories Ltd expected to post earnings of ₹13.28 a share - Earnings Preview
Airtel Africa delays mobile money division's IPO as Iran war-driven costs loom
TATACHEM: Net loss of ₹1,715 crore driven by US goodwill impairment; dividend held at ₹11.00 per share
Computer Age Management Services Recommends Final Dividend Of 4 Rupees Per Equity Share
Manappuram Finance returns to profit at ₹404 crore in Q4, NII up 2.6%; declares dividend
New building codes ease height restrictions on hospitals
Sobha Q4 net profit doubles to ₹92 crore as revenue surges 60%; declares ₹6 dividend
SOBHA: Strong revenue and profit growth, ₹6 dividend proposed, and unqualified audit opinions issued
AMBUJACEM: Revenue and profits rose sharply on acquisitions, with a ₹2.00 dividend proposed
GODREJPROP: FY26 saw robust consolidated profit and revenue growth, with a ₹10 dividend proposed
Divi's Labs Q3 net profit slips 1% on labour‑code charge; revenue up 12%
VAIBHAVGBL: H1 FY26 saw robust revenue and profit growth, with interim dividends of ₹3.00 per share
Bonus, Dividend, Stock Split Alert: These shares have their record dates this week
VAIBHAVGBL: Quarterly profit rose to Rs. 8,980.42 lakhs; total dividend for nine months is Rs. 4.50 per share
Bonus, Dividend Alert: Four stocks with important corporate actions this week
Thyrocare Q3: Profit up nearly 37%, EBITDA surges 47%; diagnostics drive margin expansion
Tanla Platforms Q4 Results: Profit rises 17%, margins stable; dividend declared
TANLA: Revenue grew year-over-year, dividend declared, and tax demand disclosed as contingent liability
Syngene International Q4 net profit falls 19%, but revenue up 2%; declares dividend
Sun TV Network Declared Interim Dividend Of 1.25 Rupees Per Share
Sun TV Network declares interim dividend of ₹1.25 per share for FY26
Strides Pharma Science Says Unit Gets USFDA EIR Report For Formulations Facility At Chestnut Ridge
Strides Pharma US arm receives closure report for Chest Ridge facility after USFDA inspection
Strides Pharma Science Enters Agreement To Buy, In-License Generic Brands From Sandoz In Africa
Strides Pharma to acquire, in-license Sandoz generic brands in Africa for $12 million upfront
As Strides Pharma stabilises balance sheet, focus shifts to growth beyond the US
ROUTE: Q3 FY26 profit was ₹102.56 crore on revenue of ₹1,107.06 crore, with a ₹3 interim dividend declared
METROPOLIS: Double-digit growth in revenue and profit, led by premium and specialty diagnostics
Max Healthcare shares get an upgrade, target raise from HSBC despite near-term challenges
Max Healthcare to acquire controlling stake in Kalinga Hospital for ₹300 crore
Max Healthcare Institute Ltd Approves Acquisition Of 58.39% Controlling Stake In Kalinga Hospital
Max Healthcare Institute GST demand of ₹55 crore fully withdrawn after rectification order
L&T Tech Q4 misses Street estimates, margin improves; ₹40 dividend declared
LTTS: Revenue grew, profit remained stable, Rs. 40/share dividend proposed, SWC business sold
LAURUSLABS: Strong revenue and profit growth in FY26, with robust cash flows and interim dividend declared
Laurus Labs Approves Investment Up To EUR 9.8 Million In KRKA Pharma
IEX Q4 Results | Net profit rises 11% on high revenue growth; ₹2 dividend declared
HFCL: Record FY26 revenue and profit growth, with order book at ₹21,206 crore and 20% dividend proposed
Glenmark Pharma To Directly Commercialize And Distribute Ryaltris In U.S. Effective
Glenmark Pharma Gets Tax Demand And Penalty Of 160.5 Million Rupees Each
Glenmark to directly commercialise Ryaltris in US, expanding innovative portfolio
Glenmark Pharma Receives U.S. FDA Approval For Progesterone Vaginal Inserts, 100 Mg
Glenmark Pharma gets USFDA nod for progesterone inserts; eyes $59 million market
Hospitals brace for 'soft' quarter as US-Iran war disrupt international travel
Hospital chains tap new markets as West Asia conflict slows medical tourism
Fortis Healthcare Unit Receives Income Tax Order With Demand Of 1.49 Billion Rupees
EDELWEISS: PAT up 27% YoY to ₹680 Cr, revenue at ₹10,865 Cr, and ₹1.50 dividend per share recommended
Dalmia Bharat Recommends Final Dividend Of 5 Rupees/Share
CDSL: FY 2025-26 saw higher revenue but lower net profit, with a ₹12.75/share dividend proposed
AWL Agri Q4 net profit jumps 55% on record revenue growth; declares dividend
Atul Q4 Results: Profit jumps 66%, margin expands; board recommends ₹30 dividend
ATUL: Strong revenue and profit growth, dividend proposed, and MD reappointed for five years
AstraZeneca Pharma Q3 Results: Topline jumps on oncology, biopharma push; margin slips
AstraZeneca Pharma India gets approval for Imfinzi in liver cancer treatment
Astrazeneca Pharma India Receives Permission To Import Durvalumab (Imfinzi) For Additional Indication
AstraZeneca Pharma gets CDSCO nod to import leukaemia drug Calquence 100 mg tablets
Alkem Labs Says Board Approves Increase Investment To Upto 10.36 Bln Rupees From 5.33 Bln Rupees For Ujjain Facility
Alkem Laboratories shares crater after CEO Vikas Gupta resigns to pursue new opportunities
Alkem Labs shares fall nearly 5% after CEO resignation announcement
Alkem Labs Gets Tax Demand Of 3.3 Billion Rupees
US FDA finds violations at Alkem Labs' Daman facility after 12-day inspection
Ajanta Pharma Ltd Issues Clarification On Media Report
Trade Spotlight: How should you trade Ajanta Pharma, HFCL, Timken India, Linde India, Supreme Industries, and others on March 13?
Ajanta Pharma Says US FDA Issues Form-483 With 5 Observations At Ajanta Pharma Paithan Facility
Ajanta Pharma's Paithan plant gets five observations from USFDA; stock volatile
Nykaa shares fall even after strong Q4 update; Street divided on whether stock can rally
Trent margins shine in Q4 but Street divided on valuation and demand outlook
Torrent Pharma Says To Launch Generic Oral Semaglutide In India
Torrent Pharma's Gujarat oncology plant inspection by USFDA concludes with zero observations
Torrent Pharma Says USFDA Inspected Its Bileshwarpura (Oncology) Facility From 06-Apr-26 To 10-Apr-26
Indian pharma market ends FY26 strong as volume growth revives, chronic therapies lead
RECLTD: Record net profit, robust asset quality, and highest dividend mark a standout FY 2025-26
REC profit drops sharply in Q4, but company still announces dividend
Oracle Financial Q4 profit jumps 38%, margin expands; ₹270 dividend declared
Oracle Financial shares surge 8%: Here's how much dividend shareholders have received since 2020
Info Edge shares fall 4% from day's high after Q4 update; Street divided on outlook
Info Edge stock slips over 2% after Q4 billings miss expectations; brokerages divided on outlook
Lupin launches dapagliflozin tablets 5 & 10 mg in US after FDA approval
Lupin Incorporates Wholly Owned Subsidiary Lupin (Thailand) In Thailand
Lupin receives Form 483 and three observations from USFDA for New Jersey facility
Lupin Launches Dapagliflozin And Metformin Hydrochloride Extended-Release Tablets In The United States
Here's why shares of Lupin and Zydus Life are under pressure on Tuesday
Jindal Steel Q4 profit at ₹1,041 crore; ₹2 dividend announced
IRCTC: Strong revenue and profit growth with interim dividend declared; legal matters resolved favorably
IRCTC Q3 Results: Net profit and revenue up; declares ₹3.50 dividend
ACC: Strong revenue growth, stable profits, and a ₹7.50 dividend amid legal and regulatory challenges
Apollo Hospitals Says Apollo Healthco Buys 100% Of Apollo Consumer Products For 900,000 Rupees
Apollo Hospitals Approves Establishment Of Multi-Speciality Hospital At Dwarka, New Delhi
Apollo Hospitals Says Further Bought Shares In Apollo Health And Lifestyle For 186.9 Million Rupees
Temasek's India hospital bet finds a pulse
Bajaj Finserv Q4 profit rises 5%; board recommends 150% dividend
DIVISLAB: Revenue and profit rose in Q3 FY26, led by custom synthesis and strong export momentum
Divis Laboratories shares decline 2.11% amid high volume trading today
Accumulate Divis Laboratories; target of Rs 6850: Prabhudas Lilladher
Divi's Laboratories gets draft tax order proposing ₹571 crore additions for FY23
Cipla shares under pressure after USFDA import alert on key supplier
Neutral Cipla; target of Rs 1307: Motilal Oswal
Dr Reddy's shares gain after Canada nod for semaglutide; marking first G7 approval
Dr Reddy's Receives Health Canada Approval For Semaglutide Injection
Indian pharma's US bet hinges on easy turnaround
Buy Sun Pharma; target of Rs 2300: Choice Institutional Equities
Buy Sun Pharmaceutical Industrie; target of Rs 1900: Prabhudas Lilladher
Sun Pharma to use Organon deal to revive brands, expand licensing pipeline
Key facts: Adani Ports revenue, margin gains; dividend, capex, upgrades
HINDUNILVR: Revenue up 5% to ₹63,763 crore, profit flat, total dividend ₹41 per share declared